Sales growth coupled with clinical progress for its products helped buoy molecular imaging firm Advanced Accelerator Applications (AAA) to higher financial ground in 2014.
Total sales in 2014 increased 30% to 69.9 million euros, compared with 53.8 million euros for all of 2013. The company also decreased its net loss to 10.8 million euros, compared with a net loss of 12.8 million euros for the full year 2013.
Fourth-quarter sales increased 32% to 19.7 million euros, compared with 14.9 million euros in 2013's fourth quarter.
The fourth-quarter net loss was reduced to 8.4 million euros, compared with a net loss of 10.1 million euros in the same quarter a year ago.